| Literature DB >> 17903841 |
S K Velioğlu1, M Ozmenoğlu, C Boz.
Abstract
Intravenous immunoglobulin (IVIg) therapy is used increasingly for different immune-mediated diseases, such as the Guillain-Barre syndrome. We report the case of a 55-year-old man who developed a cerebral infarction 2 days after completion of treatment with intravenous immunoglobulin for Guillain-Barre syndrome.Entities:
Year: 2001 PMID： 17903841 DOI： 10.1053/jscd.2001.123772
Source DB: PubMed Journal: J Stroke Cerebrovasc Dis ISSN： 1052-3057 Impact factor: 2.136